KDP vs. MRNA
KDP (Keurig Dr Pepper Inc.) and MRNA (Moderna, Inc.) are both stocks. KDP operates in Beverages - Non-Alcoholic (Consumer Defensive), while MRNA operates in Biotechnology (Healthcare). Over the past 5 years, KDP returned 0.48%/yr vs -25.59%/yr for MRNA. At a 0.09 correlation, their price movements are largely independent.
Performance
KDP vs. MRNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KDP achieves a 15.16% return, which is significantly lower than MRNA's 69.24% return.
KDP
- 1D
- 1.54%
- 1M
- 9.61%
- YTD
- 15.16%
- 6M
- 9.30%
- 1Y
- -0.75%
- 3Y*
- 3.13%
- 5Y*
- 0.48%
- 10Y*
- 10.46%
MRNA
- 1D
- 0.54%
- 1M
- 1.77%
- YTD
- 69.24%
- 6M
- 69.42%
- 1Y
- 87.14%
- 3Y*
- -26.94%
- 5Y*
- -25.59%
- 10Y*
- —
KDP vs. MRNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
KDP Keurig Dr Pepper Inc. | 15.16% | -10.14% | -1.05% | -4.24% | -1.23% | 17.49% | 13.03% | 15.43% | -1.31% |
MRNA Moderna, Inc. | 69.24% | -29.08% | -58.19% | -44.63% | -29.28% | 143.11% | 434.10% | 28.09% | -30.59% |
Correlation
The correlation between KDP and MRNA is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Dec 7, 2018 | 0.09 |
Fundamentals
KDP:
$43.24B
MRNA:
$19.71B
KDP:
$1.34
MRNA:
-$8.16
KDP:
2.55
MRNA:
8.78
KDP:
2.07
MRNA:
2.66
KDP:
$16.94B
MRNA:
$2.23B
KDP:
$9.11B
MRNA:
-$309.00M
KDP:
$3.70B
MRNA:
-$3.02B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KDP vs. MRNA — Risk / Return Rank
KDP
MRNA
KDP vs. MRNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Keurig Dr Pepper Inc. (KDP) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KDP | MRNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.32 | ||
| Sortino ratioReturn per unit of downside risk | -1.99 | ||
| Omega ratioGain probability vs. loss probability | 1.02 | 1.24 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | -0.04 | 2.34 | -2.38 |
| Martin ratioReturn relative to average drawdown | -0.06 | 4.59 | -4.65 |
Loading charts...
Drawdowns
KDP vs. MRNA - Drawdown Comparison
The maximum KDP drawdown since its inception was -58.97%, smaller than the maximum MRNA drawdown of -95.38%. Use the drawdown chart below to compare losses from any high point for KDP and MRNA.
Loading charts...
Drawdown Indicators
| KDP | MRNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.97% | -95.38% | +36.41% |
Max Drawdown (1Y)Largest decline over 1 year | -27.48% | -35.51% | +8.03% |
Max Drawdown (3Y)Largest decline over 3 years | -30.99% | -86.58% | +55.59% |
Max Drawdown (5Y)Largest decline over 5 years | -31.20% | -95.38% | +64.18% |
Max Drawdown (10Y)Largest decline over 10 years | -36.87% | — | — |
Current DrawdownCurrent decline from peak | -12.28% | -89.70% | +77.42% |
Average DrawdownAverage peak-to-trough decline | -8.80% | -57.06% | +48.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.87% | 18.06% | -0.19% |
Volatility
KDP vs. MRNA - Volatility Comparison
The current volatility for Keurig Dr Pepper Inc. (KDP) is 5.54%, while Moderna, Inc. (MRNA) has a volatility of 17.56%. This indicates that KDP experiences smaller price fluctuations and is considered to be less risky than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KDP | MRNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.54% | 17.56% | -12.02% |
Volatility (6M)Calculated over the trailing 6-month period | 17.18% | 48.82% | -31.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.89% | 64.75% | -36.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.08% | 66.49% | -45.41% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.87% | 72.15% | -48.28% |
Dividends
KDP vs. MRNA - Dividend Comparison
KDP's dividend yield for the trailing twelve months is around 2.90%, while MRNA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KDP Keurig Dr Pepper Inc. | 2.90% | 3.28% | 2.72% | 2.45% | 2.14% | 1.83% | 1.88% | 2.07% | 407.49% | 2.39% | 2.34% | 2.06% |
MRNA Moderna, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
KDP vs. MRNA - Financials Comparison
This section allows you to compare key financial metrics between Keurig Dr Pepper Inc. and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
KDP and MRNA have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MRNA has higher volatility (17.56%) compared to KDP (5.54%). In terms of maximum drawdown, KDP dropped -58.97% vs MRNA's -95.38%.
MRNA currently has the higher Sharpe Ratio (1.28 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KDP and MRNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer